Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding IBRN?
Track your performance easily
IBRN Price & Analysis
IBRN ETF Chart & Stats
Day’s Range― - ―
52-Week Range$21.02 - $28.74
Previous Close$26.5
VolumeN/A
Average Volume (3M)465.00
AUM3.93M
NAV26.51
Expense Ratio0.47%
Holdings Count57
Beta1.24
Inception DateAug 24, 2022
Last Dividend Ex-Date
Dec 20, 2023Dividend Yield
0.01 (0.05%)Shares Outstanding150,024
Standard Deviation0.07
10 Day Avg. Volume429
30 Day Avg. Volume465
Alpha-0.00445
iShares Neuroscience and Healthcare ETF (IBRN) Fund Flow Chart
iShares Neuroscience and Healthcare ETF (IBRN) 1 year Net Flows: -$1M
IBRN ETF News
PremiumStock Analysis & Ideas
JPMorgan Selects These 2 Stocks as Must-Haves for 2025
IBRN ETF FAQ
What was IBRN’s price range in the past 12 months?
IBRN lowest ETF price was $21.02 and its highest was $28.74 in the past 12 months.
What is the AUM of IBRN?
As of Nov 22, 2024 The AUM of IBRN is 3.93M.
Is IBRN overvalued?
According to Wall Street analysts IBRN’s price is currently Undervalued.
Does IBRN pay dividends?
IBRN pays a Notavailable dividend of <$0.01 which represents an annual dividend yield of 0.05%. See more information on IBRN dividends here
How many shares outstanding does IBRN have?
IBRN has 150,024 shares outstanding.
Which hedge fund is a major shareholder of IBRN?
Currently, no hedge funds are holding shares in IBRN
IBRN ETF Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.
Top 10 Holdings
PTC Therapeutics
5.21%
Biohaven Ltd.
4.70%
Intra-Cellular Therapies
4.43%
Argenx
4.25%
Catalyst Pharmaceutical Partners
4.12%
Alkermes plc
4.08%
Xenon Pharmaceuticals
4.04%
Neurocrine Biosciences
3.95%
ACADIA Pharmaceuticals Inc.
3.88%
Longboard Pharmaceuticals, Inc.
3.73%
Total42.39%
ETF Description
iShares Neuroscience and Healthcare ETF
IBRN tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap.